The January 2014 edition of the Transplant Trial Watch is now available. This month’s new trials include Letermovir for post-transplant CMV infection, a suggestion that Alemtuzumab increases de-novo DSA production and a phase I study of a novel TLR-2 monoclonal antibody.
You can read the CET’s summaries of these trials (and more) on the CET website, or via our app for iPhone and Android devices.